Company news
Oxurion NV news in 2026
Oxurion NV's news releases, calls and decks from 2026, newest first.
Interim Financial Report — Half-year results as of 30 June 2026 (EN)
September 30, 2026
Oxurion: Oxurion Publishes First Half 2026 Results
September 30, 2026
Oxurion: Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
September 30, 2026
Oxurion: Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
July 21, 2026
Oxurion: Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module
July 6, 2026
Oxurion: Oxurion launches a software-driven growth strategy with Exagis
June 8, 2026
Oxurion: Oxurion Announces Results on the Annual Shareholders’ Meeting of 1 June 2026
June 3, 2026
Oxurion: Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services
June 2, 2026
Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)
June 2, 2026
Publication Annual Report - Annual Shareholders Meeting
April 30, 2026
Postponement Annual Shareholders Meeting
April 7, 2026
Oxurion: Oxurion signs a letter of intent for the acquisition of an international CRO
March 19, 2026
Oxurion Extends Its Financing Program
March 10, 2026
Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO
February 27, 2026